ArticleProceedings of the National Academy of Sciences of the United States of America2021
Correction to Supporting Information for Weiler et al., mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.